Valvular Atrial Fibrillation (VAF) is a distinct category of atrial fibrillation that manifests in individuals with significant heart valve disorders. The abnormal electrical signals within the atria, or upper chambers of the heart, lead to irregular and often accelerated heartbeats. The link between VAF and valvular heart diseases, such as mitral stenosis or the presence of a mechanical heart valve, underscores the complexity of this condition. The management of VAF requires a nuanced approach, taking into account both the atrial fibrillation and the underlying valvular pathology. Healthcare professionals navigate treatment strategies based on factors like the severity of the valve disease, the overall health status of the patient, and individual considerations unique to each case. Striking a balance between addressing atrial fibrillation and managing valvular issues is crucial for effective care.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Not So Idiopathic After All: Genotype, Phenotype and IL-1 Blockade Response Converge in Recurrent Pericarditis
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Beyond the Heart in Cardiovascular Magnetic Resonance Imaging: Prevalence and Clinical Significance of Incidental Extracardiac Findings
burcu yagmur, Kyrenia University Hospital, Cyprus
Title : Cardiovascular mortality in colon cancer a patient characteristics analysis: Population-based study
Nouf, KAU, Saudi Arabia
Title : Improving Screening and Treatment of Iron Deficiency in Patients with Heart Failure with Reduced Ejection Fraction: A Two-Cycle Quality Improvement Project
Danish Malik, University Hospitals Dorset NHS Foundation Trust, United Kingdom